Insulin aspart 

Insulin aspart 

Cat. No.: DIA-0230721

Size: 100 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 116094-23-6
Synonyms B28Asp, B28-Asp-insulin, INA-X 14, Insulin X 14
Formula C256H381N65O79S6
Target Insulin
Product Description Insulin aspart (B28Asp) is a fast-acting analog of human insulin. Insulin aspart provides more rapid absorption than regular human insulin after subcutaneous administration. Insulin aspart can be used for researching diabetes.
Format & Storage
Format Solid
Purity > 99%
Shipping Shipped on dry ice.
Storage Protect from light. Powder: -80 °C, 2 years; -20 °C, 1 year. In solvent: -80 °C, 6 months; -20 °C, 1 month (protect from light).
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top